Phase

n/a (4,391)

phase 2 (1,533)

phase 3 (1,207)

phase 4 (1,148)

phase 1 (1,025)

phase 1/phase 2 (403)

phase 2/phase 3 (262)

early phase 1 (139)

Funder Type

Other (11,390)

Industry (2,186)

NIH (978)

U.S. Fed (122)

Study Type

Interventional (10,108)

Observational (4,120)

Observational [Patient Registry] (423)

Expanded Access (25)

Bloodstream infections caused by MDR Enterobacteriaceae

Showing 26 - 50 of >10,000

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Developing Infections in Patients Colonized by CP-KPC

Recruiting

Carbapenemase-Producing Enterobacteriaceae

Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina

Hospital Italiano de Buenos Aires

Aug 5, 2022

Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria Trial

Not yet recruiting

Gram Negative Pneumonia
+2 more

Fluorothiazinone, tablets 300 mg at a dose of 2400 mg/day
Placebo

(no location specified)

Nov 14, 2023

Enterobacteriaceae Infections, Multi-antibiotic Resistance Trial in Roma (Donor - FMT, Placebo FMT)

Not yet recruiting

Enterobacteriaceae Infections
Multi-antibiotic Resistance

Donor - FMT
Placebo FMT

Roma, Italy

Giovanni Cammarota

Mar 28, 2023

Carbapenem-Resistant Enterobacteriaceae Infection Trial in Riyadh (Ceftazidime-avibactam, Colistin)

Recruiting

Carbapenem-Resistant Enterobacteriaceae Infection

Riyadh, Saudi Arabia

King Faisal Specialist Hospital & Research Centre

Jun 20, 2022

Acinetobacter Infections Trial in Bangkok (Colistin, Minocycline, Placebo)

Recruiting

Acinetobacter Infections

Colistin
+2 more

Bangkok, Thailand

Faculty of Medicine Siriraj Hospital, Mahidol University

Jan 13, 2023

Enterobacteria Infections Trial in Paris, Bobigny, Corbeil-Essonnes (Control (Patients colonized rectally with ESBL-producing

Recruiting

Enterobacteria Infections

Control (Patients colonized rectally with ESBL-producing enterobacteria without antibiotic pressure)
Case (Patients colonized rectally with ESBL-producing enterobacteriaceae, with antibiotic pressure)

Paris, Groupe Hospitalier Paris Saint-Joseph, France
+3 more

Aug 17, 2022

Patients With Infection by Resistant Microorganism

Enrolling by invitation

Pneumonia
+10 more

Pathogen resistant phenotype

Sevilla, Spain

Hospital Universitario Virgen Macarena

May 18, 2023

Risk Factors for Multidrug Resistant Bacteria at ICU Admission

Not yet recruiting

Multi Drug Resistant Bacteria

Identification o Multi Drug Resistant Bacteria

(no location specified)

Aug 2, 2023

Multi-drug Resistant Organism Trial in Atlanta (Microbiome Therapeutic, Placebo)

Not yet recruiting

Multi-drug Resistant Organism

Microbiome Therapeutic
Placebo

Atlanta, Georgia
+4 more

Apr 18, 2023

Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

Recruiting

Tuberculosis, Multidrug-Resistant

Delamanid
+4 more

Dasmariñas, Philippines
+1 more

Jun 21, 2022

In Vitro Activity of Ceftolozane-tazobactam Against Contemporary

Completed

Nosocomial Infection

Smolensk, Russian Federation

The Interregional Association for Clinical Microbiology and Anti

Dec 16, 2020

Gram-negative Bacteremia Trial (De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular

Not yet recruiting

Gram-negative Bacteremia

De-escalation VS No De-escalation
+4 more

(no location specified)

May 30, 2023

Nosocomial Infections in Patients With ARDS Treated With ECMO

Not yet recruiting

Acute Respiratory Distress Syndrome
+2 more

Collection of blood and bronchoalveolar samples to study Pharmacokinetics of ceftazidime/avibactam, meropenem/varbobactam, ceftolozane/tazobactam, or cefiderocol

Milan, Italy

Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico

Sep 30, 2022

Postoperative Peritonitis Trial in France (rapid molecular diagnosis, conventional method analysis)

Recruiting

Postoperative Peritonitis

rapid molecular diagnosis
conventional method analysis

Amiens, France
+6 more

Jan 12, 2023

Recipients Gut Microbiota After Fecal Microbiota Transplantation

Recruiting

Clostridioides Difficile Infection Recurrence

FMT from healthy donors

Roma, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Feb 13, 2023

Short Versus Long Duration of Therapy for Streptococcus

Recruiting

Streptococcus Pneumoniae

pneumoniae bacteremia therapy

Dallas, Texas

Methodist Dallas Medical Center

Oct 17, 2023

Central Venous Catheter Related Bloodstream Infection, Catheter-Related Infections, Bloodstream Infection Due to Central Venous

Recruiting

Central Venous Catheter Related Bloodstream Infection
+2 more

clorhexidine gluconate bathing

Istanbul, Kadıköy, Turkey

IMU

Aug 12, 2023

Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)

Recruiting

Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus

Paris, France

François-Xavier Lescure

Dec 7, 2022

Burns Trial in Gaziantep (Patients' procalcitonin, thrombocyte, and leukocyte levels were assessed every other day for 4 weeks,

Completed

Burns

Patients' procalcitonin, thrombocyte, and leukocyte levels were assessed every other day for 4 weeks, beginning on the first day they were admitted to the burn center.